The abstract is read at the publisher; the summary is JClub's.
OSTM1 functions as a tumor suppressor in IL3-dependent Ba/F3 cells and in mice, where Cd19-Cre-driven Ostm1 deletion cooperates with Cdkn2a loss to cause near-complete B-cell lymphomagenesis.
- Why it matters: OSTM1 is frequently deleted or downregulated in human B-cell malignancies, but its role in lymphomagenesis and the pathway linking OSTM1 loss to tumor biology were unclear.
- What they did: A genome-wide forward CRISPR/Cas9 screen in IL3-dependent Ba/F3 cells identified OSTM1; in mice, B-cell-specific monoallelic or biallelic Ostm1 deletion with Cdkn2a loss was tested, and OSTM1–PDE3B interaction plus PDE3B degradation were examined.
- The result: OSTM1 promotes proteasomal degradation of PDE3B, and Pde3b silencing reverses oncogenic transformation driven by Ostm1 loss, defining an OSTM1/PDE3B/cAMP/PKA/CREB axis as a potential therapeutic vulnerability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.